MCB Download to Citation Manager
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 10 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.02159-07v1
28/10/3273    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Namekata, K.
Right arrow Articles by Harada, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Namekata, K.
Right arrow Articles by Harada, T.
Mol. Cell. Biol. doi:10.1128/MCB.02159-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Interleukin-1 stimulates glutamate uptake in glial cells by accelerating membrane trafficking of Na+/K+-ATPase via actin depolymerization

Kazuhiko Namekata, Chikako Harada, Kuniko Kohyama, Yoh Matsumoto, and Takayuki Harada*

Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan; Department of Molecular Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan

* To whom correspondence should be addressed. Email: harada{at}tmin.ac.jp.


   Abstract

Interleukin-1 (IL-1) is a mediator of brain injury induced by ischemia, trauma, and chronic neurodegenerative disease. IL-1 also has a protective role by preventing neuronal cell death from glutamate neurotoxicity. However, the cellular mechanisms of IL-1 action remain unresolved. In the mammalian retina, glutamate/aspartate transporter (GLAST) is a Na+-dependent, major glutamate transporter localized to Müller glial cells, and loss of GLAST leads to glaucomatous retinal degeneration (T. Harada, C. Harada, K. Nakamura, H.A. Quah, A. Okumura, K. Namekata, T. Saeki, M. Aihara, H. Yoshida, A. Mitani, and K. Tanaka, J. Clin. Invest. 117:1763-1770, 2007). We show here that IL-1 increases glutamate uptake in Müller cells by a mechanism that involves increased membrane Na+/K+-ATPase localization, required for counteracting the Na+-glutamate cotransport. IL-1 activated the p38 mitogen-activated protein kinase (MAPK)/capase-11 pathway, which destabilizes the actin cytoskeleton allowing Na+/K+-ATPase membrane redistribution. Furthermore, pretreatment with IL-1 protected retinal neurons from glutamate neurotoxicity through p38 MAPK signalling. Our observations suggested IL-1 as a potential neuroprotective agent by modulating the functions of the glia-neuron network.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.